BPharm, MD, MMed, SCHP, Dermatology Research Fellow, Department of Dermatology, Westmead Hospital, Westmead, NSW; Clinical Associate Lecturer, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW
Apremilast, a phosphodiesterase 4 inhibitor, presents an appealing treatment option for patients with both psoriasis and ulcerative colitis.
Important considerations when treating patients with warts include the location of the wart, the evidence supporting the proposed treatment and potential adverse effects of treatment.